| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/03/2008 |
3. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 1,464 | D | |
| Common Stock | 1,251.229(1) | D | |
| Common Stock(2) | 13,372 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| ISO (Right to Buy) | 12/01/2004(3) | 12/01/2010 | Common Stock | 5,064 | 59.23 | D | |
| ISO (Right to Buy) | 03/15/2008(4) | 03/15/2011 | Common Stock | 3,362 | 59.48 | D | |
| ISO (Right to Buy) | 04/26/2011 | 04/26/2014 | Common Stock | 1,598 | 62.55 | D | |
| ISO (Right to Buy) | 04/03/2010 | 04/03/2013 | Common Stock | 1,391 | 71.88 | D | |
| NQSO (Right to Buy) | 03/15/2006(5) | 03/15/2012 | Common Stock | 8,571 | 58.61 | D | |
| NQSO (Right to Buy) | 12/01/2004(6) | 12/01/2010 | Common Stock | 9,936 | 59.23 | D | |
| NQSO (Right to Buy) | 03/15/2005(7) | 03/15/2011 | Common Stock | 3,706 | 59.48 | D | |
| NQSO (Right to Buy) | 04/26/2008(8) | 04/26/2014 | Common Stock | 10,902 | 62.55 | D | |
| NQSO (Right to Buy) | 04/03/2007(9) | 04/03/2013 | Common Stock | 6,484 | 71.88 | D | |
| NQSO (Right to Buy) | 04/29/2009(10) | 04/29/2015 | Common Stock | 11,800 | 42.13 | D | |
| Explanation of Responses: |
| 1. These are units acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. |
| 2. The Restricted Stock Units (RSUs) were granted under the Company's Amended and Restated 1991 Equity Incentive Plan 10,000 RSUs vest in four equal annual installments of 2,500 shares each commencing July 17, 2008, and 3,372 RSUs vest in four equal annual installments of 843 shares each commencing April 29, 2009. Vested RSU's will be paid in shares of the Company's common stock on a one-to-one basis. |
| 3. This option was fully exercisable on December 1, 2007. |
| 4. This option is exercisable as follows: 1,681 shares immediately; and 1,681 shares on March 15, 2009. |
| 5. This option is exercisable as follows: 6,428 shares immediately; and 2,143 shares on March 15, 2009. |
| 6. This option was fully exercisable on December 1, 2007. |
| 7. This option is exercisable as follows: 3,620 shares immediately; and 86 shares on March 15, 2009. |
| 8. This Option is exercisable as follows: 3,125 shares immediately; 3,125 shares on April 26, 2009; 3,125 shares on April 26, 2010; and 1,527 shares on April 26, 2011. |
| 9. This option is exercisable as follows: 3,937 shares immediately; 1,969 shares on April 3, 2009; and 578 shares on April 3, 2010. |
| 10. This option is exercisable in four equal annual installments of 2,950 each commencing April 29, 2009. |
| /s/ N. Cris Prince, Attorney-in-Fact | 06/12/2008 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
POWER OF ATTORNEY
Know all men by these presents, that the undersigned hereby constitutes and appoints
each of N. Cris Prince, Andrea A. Robinson and Mark A. Schlossberg, signing
singly, the undersigned's true and lawful attorney-in-fact to execute for and on
behalf of the undersigned Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules thereunder, as may be
required as a result of the undersigned's position as an officer and/or director of
Amgen Inc. (the "Company").The undersigned hereby grants to each such attorney-in-fact full power and authority
to execute such Forms 3, 4 and 5 as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming a ll that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the rights
and powers herein granted. The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the undersigned,
are not assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Securities Exchange Act of 1934,
as amended.This Power of Attorney shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's
holdings of and transactions in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered to the foregoing
attorneys-in-fact.IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executued as of this 6th day of June, 2008.
&n bsp; /s/ Anna S. Richo
--------------------------------
Name: Anna S. Richo